EV/EBITDA:
-17.68+0.34(+1.89%)Summary
- As of today (September 16, 2025), TVTX EV/EBITDA is -17.68, with a rise of +0.34 (+1.89%) during the most recent trading session on September 15, 2025.
- Over the past year, TVTX EV/EBITDA has dropped by -13.61 (-334.40%).
- TVTX EV/EBITDA is now -3001.75% below its all-time high of -0.57.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.9% | -1.9% | -2.0% |
| 1 m1 month | -21.3% | +21.3% | +22.3% |
| 3 m3 months | -131.1% | +56.0% | +58.7% |
| 6 m6 months | -111.0% | +19.6% | +16.6% |
| ytdytd | -141.9% | +37.1% | +32.1% |
| 1 y1 year | -334.4% | +92.2% | +70.7% |
| 5 y5 years | -23.6% | +182.4% | +17.9% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.41 | -31.8% | -20.86 | +15.2% |
| 3 m | 3-month | -7.44 | -137.6% | -20.86 | +15.2% |
| 6 m | 6-month | -7.14 | -147.6% | -20.86 | +15.2% |
| 1 y | 1-year | -4.07 | -334.4% | -20.86 | +15.2% |
| 3 y | 3-year | -0.57 | -3001.8% | -20.86 | +15.2% |
| 5 y | 5-year | -0.57 | -3001.8% | -34.23 | +48.4% |
| alltime | all time | -0.57 | -3001.8% | -392.61 | +95.5% |
TVTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -17.68(+141.9%) |
| 2024 | -7.31(+335.1%) |
| 2023 | -1.68(-67.1%) |
| 2022 | -5.11(-65.3%) |
| Date | Value |
|---|---|
| 2021 | -14.74(-42.7%) |
| 2020 | -25.72(-31.8%) |
| 2015 | -37.70(+625.0%) |
| 2014 | -5.20(-8.8%) |
| 2013 | -5.70 |
FAQ
- What is Travere Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Travere Therapeutics, Inc.?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Travere Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TVTX is -17.68
What is the all time high EV/EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high EV/EBITDA is -0.57
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics, Inc. EV/EBITDA has changed by -10.37 (-141.86%) since the beginning of the year
What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -13.61 (-334.40%)